Biodexa Pharmaceuticals
BDRX | NASDAQ
$2.80
-$0.63 (-18.37%)
At close: Nov 2, 2026, 4:00 PM ET
$2.98
+$0.18 (+6.43%)
After-hours:
Nov 2, 2026, 5:04 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -4.44M | -6.37M | -6.23M | -5.73M | -6.82M | -7.08M | -8.16M | -7.66M | -5.37M | -5.46M | -7.92M |
Depreciation & Amortization | 129.29K | 189.31K | 256.82K | 252.21K | 280.22K | 286.85K | 313.56K | 350.69K | 405.68K | 405.79K | 831.2K |
Stock-Based Compensation | n/a | 97K | 230K | 283K | 163K | 28K | 38K | 123K | 152K | 89K | 38K |
Other Working Capital | n/a | n/a | 2.24M | 2.24M | n/a | -207K | -42K | 157K | -8K | n/a | 50K |
Other Non-Cash Items | -3.81M | -3.34M | -4.63M | -3.33M | -340.22K | -101.85K | 501.44K | 100.31K | -1.47M | -953.79K | 1.72M |
Deferred Income Tax | n/a | n/a | -250K | -250K | n/a | -118K | -372K | -130K | -300K | 398K | -165K |
Change in Working Capital | 1.18M | 3.79M | -391K | -3.74M | -1.04M | 158K | 292K | 164K | 140K | -487K | 177K |
Operating Cash Flow | -6.94M | -5.63M | -11.01M | -12.51M | -7.75M | -6.83M | -7.39M | -7.05M | -6.44M | -6.01M | -5.32M |
Capital Expenditures | -7.2K | -2.06K | -776K | -774K | -22K | -26K | -33K | -62K | -164K | -320K | -309K |
Cash Acquisitions | 17.89K | 17.89K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -351.48K | -279.74K | 169.05K | -165.69K | -239K | -150K | -158K | 16K | 42K | 2.82M |
Investing Cash Flow | -1.04M | -662.41K | -290.74K | -691.26K | -1.04M | -265K | -183K | -220K | -148K | -278K | 2.52M |
Debt Repayment | -447.23K | -542.23K | 150K | 152K | -93K | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -85.43K | -145.51K | -4.55M | -4.42M | 3.98M | 10.23M | 6.38M | 47K | 8.81M | 8.81M | 2.62M |
Financial Cash Flow | 7.12M | 12.87M | 9.82M | 8.78M | 8.62M | 10.23M | 6.38M | 47K | 8.81M | 8.81M | 2.62M |
Net Cash Flow | -1.04M | 8.45M | 600.1K | 1.62M | 5.43M | 1.57M | -598K | 4.63M | 9.35M | 1.26M | -62K |
Free Cash Flow | -6.95M | -5.63M | -11.53M | -13.04M | -7.77M | -6.85M | -7.42M | -7.11M | -6.6M | -6.33M | -5.63M |
Adj. Free Cash Flow | -6.95M | -5.73M | -11.76M | -13.32M | -7.94M | -6.88M | -7.46M | -7.23M | -6.76M | -6.42M | -5.67M |
Maintenance CapEx | -783.2K | -776.06K | -798K | -800K | -26K | -26K | -131.37K | -127.37K | -247.37K | -336.37K | -508K |
Growth CapEx | n/a | n/a | n/a | n/a | -29K | -62K | -65.63K | -254.63K | -225.63K | -192.63K | -189K |
Owner Earnings | -18.48M | -18.67M | -19.31M | -19.89M | -15.17M | -13.9M | -13.96M | -13.18M | -12.01M | -15.65M | -14.85M |
Add to Watchlist
Select watchlists to add or remove BDRX